$LECT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Axogen, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Axogen, Inc.. Get notifications about new insider transactions in Axogen, Inc. for free.
Page: < prev 1 2 3 4 5 5 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 01 2020 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Buy | M | 5.14 | 5,000 | 25,700 | 43,646 | 38.6 K to 43.6 K (+12.94 %) |
Jun 01 2020 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Buy | M | 3.67 | 10,000 | 36,700 | 38,646 | 28.6 K to 38.6 K (+34.91 %) |
Jun 01 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | General Counsel | Option Exercise | M | 3.50 | 125,000 | 437,500 | 0 | |
Jun 01 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | General Counsel | Buy | M | 3.50 | 125,000 | 437,500 | 231,484 | 106.5 K to 231.5 K (+117.39 %) |
Apr 29 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | M | 0.27 | 2,530 | 683 | 0 | |
Apr 29 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Buy | M | 0.27 | 2,530 | 683 | 51,056 | 48.5 K to 51.1 K (+5.21 %) |
Apr 20 2020 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Option Exercise | M | 4.81 | 11,625 | 55,916 | 0 | |
Apr 20 2020 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Buy | M | 4.81 | 11,625 | 55,916 | 658,869 | 647.2 K to 658.9 K (+1.80 %) |
Mar 18 2020 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Mar 18 2020 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Option Exercise | A | 8.61 | 24,000 | 206,640 | 24,000 | |
Mar 18 2020 | LECT | Axogen, Inc. | Billet Isabelle | Chief Strategy and ... | Option Exercise | A | 0.00 | 5,000 | 0 | 17,000 | |
Mar 18 2020 | LECT | Axogen, Inc. | Billet Isabelle | Chief Strategy and ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Mar 18 2020 | LECT | Axogen, Inc. | Billet Isabelle | Chief Strategy and ... | Option Exercise | A | 8.61 | 24,000 | 206,640 | 24,000 | |
Mar 18 2020 | LECT | Axogen, Inc. | MARTINEZ MARIA D. | Chief Human Resourc ... | Option Exercise | A | 0.00 | 5,000 | 0 | 17,000 | |
Mar 18 2020 | LECT | Axogen, Inc. | MARTINEZ MARIA D. | Chief Human Resourc ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Mar 18 2020 | LECT | Axogen, Inc. | MARTINEZ MARIA D. | Chief Human Resourc ... | Option Exercise | A | 8.61 | 24,000 | 206,640 | 24,000 | |
Mar 18 2020 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Option Exercise | A | 0.00 | 22,000 | 0 | 22,000 | |
Mar 18 2020 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Option Exercise | A | 8.61 | 43,000 | 370,230 | 43,000 | |
Mar 18 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Mar 18 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | A | 8.61 | 24,000 | 206,640 | 24,000 | |
Mar 18 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | General Counsel | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Mar 18 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | General Counsel | Option Exercise | A | 8.61 | 24,000 | 206,640 | 24,000 | |
Mar 18 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Mar 18 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | A | 8.61 | 24,000 | 206,640 | 24,000 | |
Mar 18 2020 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Option Exercise | A | 0.00 | 51,900 | 0 | 51,900 | |
Mar 18 2020 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Option Exercise | A | 8.61 | 80,200 | 690,522 | 80,200 | |
Mar 18 2020 | LECT | Axogen, Inc. | Scopelianos Angelo | VP Research & Devel ... | Option Exercise | A | 0.00 | 10,000 | 0 | 22,000 | |
Mar 18 2020 | LECT | Axogen, Inc. | Scopelianos Angelo | VP Research & Devel ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Mar 18 2020 | LECT | Axogen, Inc. | Scopelianos Angelo | VP Research & Devel ... | Option Exercise | A | 8.61 | 24,000 | 206,640 | 24,000 | |
Mar 18 2020 | LECT | Axogen, Inc. | Sandberg Eric | Chief Commercial Of ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
Mar 18 2020 | LECT | Axogen, Inc. | Sandberg Eric | Chief Commercial Of ... | Option Exercise | A | 8.61 | 24,000 | 206,640 | 24,000 | |
Feb 20 2020 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Grant | A | 0.00 | 16,015 | 0 | 647,244 | 631.2 K to 647.2 K (+2.54 %) |
Feb 20 2020 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Payment of Exercise | F | 14.68 | 5,429 | 79,698 | 631,229 | 636.7 K to 631.2 K (-0.85 %) |
Feb 20 2020 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Grant | A | 0.00 | 13,978 | 0 | 636,658 | 622.7 K to 636.7 K (+2.24 %) |
Feb 20 2020 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Grant | A | 0.00 | 675 | 0 | 28,646 | 28 K to 28.6 K (+2.41 %) |
Feb 20 2020 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Grant | A | 0.00 | 1,930 | 0 | 27,971 | 26 K to 28 K (+7.41 %) |
Feb 20 2020 | LECT | Axogen, Inc. | Scopelianos Angelo | VP Research & Devel ... | Payment of Exercise | F | 14.68 | 394 | 5,784 | 2,249 | 2.6 K to 2.2 K (-14.91 %) |
Feb 20 2020 | LECT | Axogen, Inc. | Scopelianos Angelo | VP Research & Devel ... | Grant | A | 0.00 | 1,326 | 0 | 2,643 | 1.3 K to 2.6 K (+100.68 %) |
Feb 20 2020 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Payment of Exercise | F | 14.68 | 846 | 12,419 | 20,683 | 21.5 K to 20.7 K (-3.93 %) |
Feb 20 2020 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Grant | A | 0.00 | 3,157 | 0 | 21,529 | 18.4 K to 21.5 K (+17.18 %) |
Feb 20 2020 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Payment of Exercise | F | 14.68 | 2,410 | 35,379 | 18,372 | 20.8 K to 18.4 K (-11.60 %) |
Feb 20 2020 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Grant | A | 0.00 | 7,654 | 0 | 20,782 | 13.1 K to 20.8 K (+58.30 %) |
Feb 20 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Payment of Exercise | F | 14.68 | 351 | 5,153 | 4,802 | 5.2 K to 4.8 K (-6.81 %) |
Feb 20 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Grant | A | 0.00 | 1,181 | 0 | 5,153 | 6.3 K to 5.2 K (-18.65 %) |
Feb 20 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Payment of Exercise | F | 14.68 | 573 | 8,412 | 3,972 | 4.5 K to 4 K (-12.61 %) |
Feb 20 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Grant | A | 0.00 | 1,930 | 0 | 4,545 | 2.6 K to 4.5 K (+73.80 %) |
Feb 20 2020 | LECT | Axogen, Inc. | Sandberg Eric | Chief Commercial Of ... | Payment of Exercise | F | 14.68 | 936 | 13,740 | 1,595 | 2.5 K to 1.6 K (-36.98 %) |
Feb 20 2020 | LECT | Axogen, Inc. | Sandberg Eric | Chief Commercial Of ... | Grant | A | 0.00 | 2,531 | 0 | 2,531 | 0 to 2.5 K |
Feb 20 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | General Counsel | Payment of Exercise | F | 14.68 | 529 | 7,766 | 106,484 | 107 K to 106.5 K (-0.49 %) |
Feb 20 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | General Counsel | Grant | A | 0.00 | 1,783 | 0 | 107,013 | 105.2 K to 107 K (+1.69 %) |
Feb 20 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | General Counsel | Payment of Exercise | F | 14.68 | 1,002 | 14,709 | 105,230 | 106.2 K to 105.2 K (-0.94 %) |
Feb 20 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | General Counsel | Grant | A | 0.00 | 3,377 | 0 | 106,232 | 102.9 K to 106.2 K (+3.28 %) |
Feb 20 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Payment of Exercise | F | 14.68 | 351 | 5,153 | 48,526 | 48.9 K to 48.5 K (-0.72 %) |
Feb 20 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Grant | A | 0.00 | 1,181 | 0 | 48,877 | 47.7 K to 48.9 K (+2.48 %) |
Feb 20 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Payment of Exercise | F | 14.68 | 1,498 | 21,991 | 47,696 | 49.2 K to 47.7 K (-3.05 %) |
Feb 20 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Grant | A | 0.00 | 5,049 | 0 | 49,194 | 44.1 K to 49.2 K (+11.44 %) |
Feb 20 2020 | LECT | Axogen, Inc. | Billet Isabelle | Chief Strategy and ... | Payment of Exercise | F | 14.68 | 440 | 6,459 | 6,521 | 7 K to 6.5 K (-6.32 %) |
Feb 20 2020 | LECT | Axogen, Inc. | Billet Isabelle | Chief Strategy and ... | Grant | A | 0.00 | 1,326 | 0 | 6,961 | 5.6 K to 7 K (+23.53 %) |
Feb 20 2020 | LECT | Axogen, Inc. | MARTINEZ MARIA D. | Chief Human Resourc ... | Payment of Exercise | F | 14.68 | 394 | 5,784 | 2,932 | 3.3 K to 2.9 K (-11.85 %) |
Feb 20 2020 | LECT | Axogen, Inc. | MARTINEZ MARIA D. | Chief Human Resourc ... | Grant | A | 0.00 | 1,326 | 0 | 3,326 | 2 K to 3.3 K (+66.30 %) |
Jan 17 2020 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Sell | D | 17.34 | 10,112 | 175,342 | 622,680 | 632.8 K to 622.7 K (-1.60 %) |
Jan 17 2020 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Grant | A | 0.00 | 40,000 | 0 | 632,792 | 592.8 K to 632.8 K (+6.75 %) |
Jan 03 2020 | LECT | Axogen, Inc. | Rudelius Robert James | Director | Option Exercise | M | 2.75 | 13,000 | 35,750 | 0 | |
Jan 03 2020 | LECT | Axogen, Inc. | Rudelius Robert James | Director | Payment of Exercise | F | 17.89 | 1,999 | 35,762 | 45,592 | 47.6 K to 45.6 K (-4.20 %) |
Jan 03 2020 | LECT | Axogen, Inc. | Rudelius Robert James | Director | Buy | M | 2.75 | 13,000 | 35,750 | 47,591 | 34.6 K to 47.6 K (+37.58 %) |
Dec 20 2019 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Grant | A | 0.00 | 6,250 | 0 | 599,530 | 593.3 K to 599.5 K (+1.05 %) |
Dec 20 2019 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Payment of Exercise | F | 16.73 | 183 | 3,062 | 2,127 | 2.3 K to 2.1 K (-7.92 %) |
Dec 20 2019 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Grant | A | 0.00 | 750 | 0 | 2,310 | 1.6 K to 2.3 K (+48.08 %) |
Dec 20 2019 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Payment of Exercise | F | 16.73 | 281 | 4,701 | 42,840 | 43.1 K to 42.8 K (-0.65 %) |
Dec 20 2019 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Grant | A | 0.00 | 1,150 | 0 | 43,121 | 42 K to 43.1 K (+2.74 %) |
Dec 20 2019 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Payment of Exercise | F | 16.73 | 1,049 | 17,550 | 12,433 | 13.5 K to 12.4 K (-7.78 %) |
Dec 20 2019 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Grant | A | 0.00 | 3,800 | 0 | 13,482 | 9.7 K to 13.5 K (+39.25 %) |
Dec 20 2019 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Payment of Exercise | F | 16.73 | 183 | 3,062 | 26,041 | 26.2 K to 26 K (-0.70 %) |
Dec 20 2019 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Grant | A | 0.00 | 750 | 0 | 26,224 | 25.5 K to 26.2 K (+2.94 %) |
Dec 20 2019 | LECT | Axogen, Inc. | Freitag Gregory Gene | General Counsel | Payment of Exercise | F | 16.73 | 567 | 9,486 | 101,543 | 102.1 K to 101.5 K (-0.56 %) |
Dec 20 2019 | LECT | Axogen, Inc. | Freitag Gregory Gene | General Counsel | Grant | A | 0.00 | 1,850 | 0 | 102,110 | 100.3 K to 102.1 K (+1.85 %) |
Dec 05 2019 | LECT | Axogen, Inc. | Gold Mark Stephen | Director | Gift | G | 0.00 | 7,000 | 0 | 326,771 | 333.8 K to 326.8 K (-2.10 %) |
Nov 26 2019 | LECT | Axogen, Inc. | Gold Mark Stephen | Director | Gift | G | 0.00 | 13,090 | 0 | 333,771 | 346.9 K to 333.8 K (-3.77 %) |
Oct 10 2019 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Option Exercise | M | 2.90 | 1,500 | 4,350 | 0 | |
Oct 10 2019 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Option Exercise | M | 4.81 | 5,000 | 24,050 | 0 | |
Oct 10 2019 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Buy | M | 2.90 | 1,500 | 4,350 | 25,474 | 24 K to 25.5 K (+6.26 %) |
Oct 10 2019 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Buy | M | 4.81 | 5,000 | 24,050 | 23,974 | 19 K to 24 K (+26.35 %) |
Sep 05 2019 | LECT | Axogen, Inc. | Blackford Quentin S. | Director | Option Exercise | A | 0.00 | 2,591 | 0 | 2,591 | |
Sep 05 2019 | LECT | Axogen, Inc. | Blackford Quentin S. | Director | Option Exercise | A | 15.44 | 10,710 | 165,362 | 10,710 | |
Sep 05 2019 | LECT | Axogen, Inc. | Levine Alan M | Director | Option Exercise | A | 0.00 | 2,591 | 0 | 2,591 | |
Sep 05 2019 | LECT | Axogen, Inc. | Levine Alan M | Director | Option Exercise | A | 15.44 | 10,710 | 165,362 | 10,710 | |
Sep 05 2019 | LECT | Axogen, Inc. | NEELS GUIDO J | Director | Option Exercise | A | 0.00 | 2,591 | 0 | 2,591 | |
Sep 05 2019 | LECT | Axogen, Inc. | NEELS GUIDO J | Director | Option Exercise | A | 15.44 | 10,710 | 165,362 | 10,710 | |
Sep 04 2019 | LECT | Axogen, Inc. | Wendell Amy McBride | Director | Option Exercise | A | 0.00 | 2,591 | 0 | 2,591 | |
Sep 04 2019 | LECT | Axogen, Inc. | Wendell Amy McBride | Director | Option Exercise | A | 15.44 | 10,710 | 165,362 | 10,710 | |
Sep 04 2019 | LECT | Axogen, Inc. | Rudelius Robert James | Director | Option Exercise | A | 0.00 | 2,591 | 0 | 2,591 | |
Sep 04 2019 | LECT | Axogen, Inc. | Rudelius Robert James | Director | Option Exercise | A | 15.44 | 10,710 | 165,362 | 10,710 | |
Sep 04 2019 | LECT | Axogen, Inc. | Gold Mark Stephen | Director | Option Exercise | A | 0.00 | 2,591 | 0 | 2,591 | |
Sep 04 2019 | LECT | Axogen, Inc. | Gold Mark Stephen | Director | Option Exercise | A | 15.44 | 10,710 | 165,362 | 10,710 | |
Aug 15 2019 | LECT | Axogen, Inc. | Gold Mark Stephen | Director | Buy | P | 13.04 | 100 | 1,304 | 348,761 | 348.7 K to 348.8 K (+0.03 %) |
Aug 15 2019 | LECT | Axogen, Inc. | Gold Mark Stephen | Director | Buy | P | 13.04 | 100 | 1,304 | 348,761 | 348.7 K to 348.8 K (+0.03 %) |
Aug 15 2019 | LECT | Axogen, Inc. | Gold Mark Stephen | Director | Buy | P | 13.05 | 700 | 9,135 | 348,661 | 348 K to 348.7 K (+0.20 %) |
Aug 15 2019 | LECT | Axogen, Inc. | Gold Mark Stephen | Director | Buy | P | 13.05 | 700 | 9,135 | 348,661 | 348 K to 348.7 K (+0.20 %) |
Aug 15 2019 | LECT | Axogen, Inc. | Gold Mark Stephen | Director | Buy | P | 13.13 | 1,000 | 13,130 | 347,961 | 347 K to 348 K (+0.29 %) |
Aug 15 2019 | LECT | Axogen, Inc. | Gold Mark Stephen | Director | Buy | P | 13.13 | 1,000 | 13,130 | 347,961 | 347 K to 348 K (+0.29 %) |
Aug 15 2019 | LECT | Axogen, Inc. | Gold Mark Stephen | Director | Buy | P | 13.04 | 100 | 1,304 | 346,961 | 346.9 K to 347 K (+0.03 %) |
Aug 15 2019 | LECT | Axogen, Inc. | Gold Mark Stephen | Director | Buy | P | 13.04 | 100 | 1,304 | 346,961 | 346.9 K to 347 K (+0.03 %) |
Aug 15 2019 | LECT | Axogen, Inc. | Gold Mark Stephen | Director | Buy | P | 13.04 | 100 | 1,304 | 346,861 | 346.8 K to 346.9 K (+0.03 %) |
Aug 15 2019 | LECT | Axogen, Inc. | Gold Mark Stephen | Director | Buy | P | 13.04 | 100 | 1,304 | 346,861 | 346.8 K to 346.9 K (+0.03 %) |
Aug 15 2019 | LECT | Axogen, Inc. | Gold Mark Stephen | Director | Buy | P | 13.11 | 2,000 | 26,212 | 346,761 | 344.8 K to 346.8 K (+0.58 %) |
Aug 15 2019 | LECT | Axogen, Inc. | Gold Mark Stephen | Director | Buy | P | 13.11 | 2,000 | 26,212 | 346,761 | 344.8 K to 346.8 K (+0.58 %) |
Aug 13 2019 | LECT | Axogen, Inc. | Blackford Quentin S. | Director | Buy | P | 14.10 | 14,170 | 199,797 | 39,468 | 25.3 K to 39.5 K (+56.01 %) |
Aug 13 2019 | LECT | Axogen, Inc. | Blackford Quentin S. | Director | Buy | P | 13.07 | 200 | 2,614 | 25,298 | 25.1 K to 25.3 K (+0.80 %) |
Aug 13 2019 | LECT | Axogen, Inc. | Blackford Quentin S. | Director | Buy | P | 13.10 | 1,165 | 15,262 | 25,098 | 23.9 K to 25.1 K (+4.87 %) |
Aug 12 2019 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Buy | P | 13.50 | 75,000 | 1,012,425 | 593,280 | 518.3 K to 593.3 K (+14.47 %) |
Jun 14 2019 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Sell | S | 20.00 | 20,000 | 400,000 | 18,974 | 39 K to 19 K (-51.32 %) |
Jun 14 2019 | LECT | Axogen, Inc. | Wendell Amy McBride | Director | Buy | P | 20.25 | 5,000 | 101,250 | 23,333 | 18.3 K to 23.3 K (+27.27 %) |
May 31 2019 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Option Exercise | M | 0.27 | 18,056 | 4,875 | 0 | |
May 31 2019 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Buy | M | 0.27 | 18,056 | 4,875 | 510,280 | 492.2 K to 510.3 K (+3.67 %) |
May 17 2019 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Sell | D | 21.14 | 67,952 | 1,436,594 | 1,560 | 69.5 K to 1.6 K (-97.76 %) |
May 17 2019 | LECT | Axogen, Inc. | Blackford Quentin S. | Director | Option Exercise | A | 22.99 | 23,933 | 550,220 | 23,933 | |
May 17 2019 | LECT | Axogen, Inc. | Levine Alan M | Director | Option Exercise | A | 22.99 | 23,933 | 550,220 | 23,933 | |
May 16 2019 | LECT | Axogen, Inc. | Hansen David K | VP Finance & Treasu ... | Sell | S | 22.63 | 20,000 | 452,600 | 25,588 | 45.6 K to 25.6 K (-43.87 %) |
Feb 19 2019 | LECT | AxoGen, Inc. | Zaderej Karen L. | CEO | Grant | A | 17.57 | 16,015 | 281,384 | 492,224 | 476.2 K to 492.2 K (+3.36 %) |
Feb 19 2019 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel | Grant | A | 17.57 | 3,377 | 59,334 | 100,260 | 96.9 K to 100.3 K (+3.49 %) |
Feb 19 2019 | LECT | AxoGen, Inc. | MARIANI PETER J | Chief Financial Off ... | Payment of Exercise | F | 17.57 | 2,355 | 41,377 | 9,682 | 12 K to 9.7 K (-19.56 %) |
Feb 19 2019 | LECT | AxoGen, Inc. | MARIANI PETER J | Chief Financial Off ... | Grant | A | 0.00 | 7,654 | 0 | 12,037 | 4.4 K to 12 K (+174.63 %) |
Feb 19 2019 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Payment of Exercise | F | 17.57 | 573 | 10,068 | 69,512 | 70.1 K to 69.5 K (-0.82 %) |
Feb 19 2019 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Grant | A | 0.00 | 1,930 | 0 | 70,085 | 68.2 K to 70.1 K (+2.83 %) |
Feb 19 2019 | LECT | AxoGen, Inc. | Hansen David K | VP Finance & Treasu ... | Payment of Exercise | F | 17.57 | 573 | 10,068 | 45,588 | 46.2 K to 45.6 K (-1.24 %) |
Feb 19 2019 | LECT | AxoGen, Inc. | Hansen David K | VP Finance & Treasu ... | Grant | A | 0.00 | 1,930 | 0 | 46,161 | 44.2 K to 46.2 K (+4.36 %) |
Feb 19 2019 | LECT | AxoGen, Inc. | Donovan Michael Patrick | VP Operations | Payment of Exercise | F | 17.57 | 573 | 10,068 | 38,974 | 39.5 K to 39 K (-1.45 %) |
Feb 19 2019 | LECT | AxoGen, Inc. | Donovan Michael Patrick | VP Operations | Grant | A | 0.00 | 1,930 | 0 | 39,547 | 37.6 K to 39.5 K (+5.13 %) |
Feb 19 2019 | LECT | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Payment of Exercise | F | 17.57 | 1,498 | 26,320 | 41,971 | 43.5 K to 42 K (-3.45 %) |
Feb 19 2019 | LECT | AxoGen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Grant | A | 0.00 | 5,079 | 0 | 43,469 | 38.4 K to 43.5 K (+13.23 %) |
Feb 19 2019 | LECT | AxoGen, Inc. | Gingrich Jon S. | Chief Commercial Of ... | Payment of Exercise | F | 17.57 | 1,342 | 23,579 | 4,190 | 5.5 K to 4.2 K (-24.26 %) |
Feb 19 2019 | LECT | AxoGen, Inc. | Gingrich Jon S. | Chief Commercial Of ... | Grant | A | 0.00 | 3,859 | 0 | 5,532 | 1.7 K to 5.5 K (+230.66 %) |
Jan 22 2019 | LECT | AxoGen, Inc. | Sandberg Eric | Chief Commercial Of ... | Option Exercise | A | 16.17 | 45,000 | 727,650 | 45,000 | |
Jan 22 2019 | LECT | AxoGen, Inc. | Sandberg Eric | Chief Commercial Of ... | Option Exercise | A | 16.17 | 45,000 | 727,650 | 45,000 | |
Dec 31 2018 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | A | 0.00 | 4,600 | 0 | 4,600 | |
Dec 31 2018 | LECT | AxoGen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | A | 19.17 | 18,500 | 354,645 | 18,500 | |
Dec 31 2018 | LECT | AxoGen, Inc. | Donovan Michael Patrick | VP Operations | Option Exercise | A | 0.00 | 4,600 | 0 | 4,600 | |
Dec 31 2018 | LECT | AxoGen, Inc. | Donovan Michael Patrick | VP Operations | Option Exercise | A | 19.17 | 18,500 | 354,645 | 18,500 | |
Dec 31 2018 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel | Option Exercise | A | 0.00 | 4,600 | 0 | 4,600 | |
Dec 31 2018 | LECT | AxoGen, Inc. | Freitag Gregory Gene | General Counsel | Option Exercise | A | 19.17 | 18,500 | 354,645 | 18,500 | |
Dec 31 2018 | LECT | AxoGen, Inc. | Zaderej Karen L. | CEO | Option Exercise | A | 0.00 | 17,600 | 0 | 17,600 | |
Dec 31 2018 | LECT | AxoGen, Inc. | Zaderej Karen L. | CEO | Option Exercise | A | 19.17 | 59,700 | 1,144,449 | 59,700 | |
Dec 31 2018 | LECT | AxoGen, Inc. | MARIANI PETER J | Chief Financial Off ... | Option Exercise | A | 0.00 | 10,500 | 0 | 10,500 | |
Dec 31 2018 | LECT | AxoGen, Inc. | MARIANI PETER J | Chief Financial Off ... | Option Exercise | A | 19.17 | 41,800 | 801,306 | 41,800 | |
Dec 31 2018 | LECT | AxoGen, Inc. | Scopelianos Angelo | VP Research & Devel ... | Option Exercise | A | 0.00 | 4,600 | 0 | 4,600 | |
Dec 31 2018 | LECT | AxoGen, Inc. | Scopelianos Angelo | VP Research & Devel ... | Option Exercise | A | 19.17 | 32,900 | 630,693 | 32,900 | |
Dec 31 2018 | LECT | AxoGen, Inc. | MARTINEZ MARIA D. | Chief Human Resourc ... | Option Exercise | A | 0.00 | 4,600 | 0 | 4,600 | |
Dec 31 2018 | LECT | AxoGen, Inc. | MARTINEZ MARIA D. | Chief Human Resourc ... | Option Exercise | A | 19.17 | 23,200 | 444,744 | 23,200 | |
Dec 31 2018 | LECT | AxoGen, Inc. | Billet Isabelle | Chief Strategy and ... | Option Exercise | A | 0.00 | 4,600 | 0 | 4,600 | |
Dec 31 2018 | LECT | AxoGen, Inc. | Billet Isabelle | Chief Strategy and ... | Option Exercise | A | 19.17 | 23,200 | 444,744 | 23,200 |